DOW JONES27,679.99-280.81 -1.00%
S&P 5003,192.94-32.95 -1.02%
NASDAQ9,090.14-131.14 -1.42%

Outlook Therapeutics Q4 EPS $0.05, Sales $5.853M

Outlook Therapeutics (NASDAQ:OTLK) reported quarterly earnings of $0.05 per share. The company reported $5.853 million in sales this quarter.

Benzinga · 12/19/2019 13:17

Outlook Therapeutics (NASDAQ:OTLK) reported quarterly earnings of $0.05 per share. The company reported $5.853 million in sales this quarter.